Determining the Benefits of the New York City Trans Fat Ban
Authors: Sonia Y. Angell
Journal: Annals of Internal Medicine (2010)

Letters2 February 2010Determining the Benefits of the New York City Trans Fat BanSonia Y. Angell, MD, MPH, Lynn Dee Silver, MD, MPH, and Gail P. Goldstein, MPHSonia Y. Angell, MD, MPHFrom New York City Department of Health and Mental Hygiene, New York, NY 10007.Search for more papers by this author, Lynn Dee Silver, MD, MPHFrom New York City Department of Health and Mental Hygiene, New York, NY 10007.Search for more papers by this author, and Gail P. Goldstein, MPHFrom New York City Department of Health and Mental Hygiene, New York, NY 10007.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-152-3-201002020-00018 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:Regarding Dr. Ross's comment, evidence supporting restriction of TFA use is not limited to observational studies. A multitude of controlled feeding trials (1) have assessed the effect of TFAs on serum lipid profiles. Meta-analyses of up to 60 of these trials (2, 3) show a relative increase in low-density lipoprotein cholesterol levels and a decrease in high-density lipoprotein cholesterol levels when TFAs are consumed, compared with saturated or cis unsaturated fats. As Gerberding says in her accompanying editorial (4), the science for eliminating exposure is “rock solid.”Mr. Satin expresses frustration that measuring the isolated effect of TFA ...References1. Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington, DC: National Academies Pr; 2002. Google Scholar2. Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003;77:1146-55. [PMID: 12716665] CrossrefMedlineGoogle Scholar3. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med. 2006;354:1601-13. [PMID: 16611951] CrossrefMedlineGoogle Scholar4. Gerberding JL. Safer fats for healthier hearts: the case for eliminating dietary artificial trans fat intake [Editorial]. Ann Intern Med. 2009;151:137-8. [PMID: 19620167] LinkGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From New York City Department of Health and Mental Hygiene, New York, NY 10007.Disclosures: None disclosed. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoCholesterol Control Beyond the Clinic: New York City's Trans Fat Restriction Sonia Y. Angell , Lynn Dee Silver , Gail P. Goldstein , Christine M. Johnson , Deborah R. Deitcher , Thomas R. Frieden , and Mary T. Bassett Safer Fats for Healthier Hearts: The Case for Eliminating Dietary Artificial Trans Fat Intake Julie Louise Gerberding Determining the Benefits of the New York City Trans Fat Ban Gilbert L. Ross Determining the Benefits of the New York City Trans Fat Ban Morton Satin Metrics 2 February 2010Volume 152, Issue 3Page: 194-195KeywordsCoronary heart diseaseFatsFoodHealth surveysNutritionObservational studiesOilsPrevention, policy, and public health ePublished: 2 February 2010 Issue Published: 2 February 2010 CopyrightCopyright © 2010 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...